Literature DB >> 26072030

Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.

Satoshi Hara1, Namiko Kobayashi2, Kazuo Sakamoto2, Toshiharu Ueno2, Shun Manabe2, Yasutoshi Takashima2, Juri Hamada3, Ira Pastan4, Akiyoshi Fukamizu3, Taiji Matsusaka5, Michio Nagata6.   

Abstract

Intracapillary foam cell infiltration with podocyte alterations is a characteristic pathology of focal segmental glomerulosclerosis (FSGS). We investigated the possible role of podocyte injury in glomerular macrophage and foam cell infiltration in a podocyte-selective injury model (NEP25 mice) and hypercholesterolemic model [low-density lipoprotein receptor deficiency (LDLR(-/-)) mice] with doxorubicin-induced nephropathy. Acute podocyte selective injury alone failed to induce glomerular macrophages in the NEP25 mice. However, in the doxorubicin-treated hypercholesterolemic LDLR(-/-) mice, glomerular macrophages/foam cells significantly increased and were accompanied by lipid deposition and the formation and ingestion of oxidized phospholipids (oxPLs). Glomerular macrophages significantly correlated with the amount of glomerular oxPL. The NEP25/LDLR(-/-) mice exhibited severe hypercholesterolemia, glomerular lipid deposition, and renal dysfunction. Imaging mass spectrometry revealed that a major component of oxidized low-density lipoprotein, lysophosphatidylcholine 16:0 and 18:0, was present only in the glomeruli of NEP25/LDLR(-/-) mice. Lysophosphatidylcholine 16:0 stimulated mesangial cells and macrophages, and lysophosphatidylcholine 18:0 stimulated glomerular endothelial cells to express adhesion molecules and chemokines, promoting macrophage adhesion and migration in vitro. In human FSGS, glomerular macrophage-derived foam cells contained oxPLs accompanied by the expression of chemokines in the tuft. In conclusion, glomerular lipid modification represents a novel pathology by podocyte injury, promoting FSGS. Podocyte injury-driven lysophosphatidylcholine de novo accelerated glomerular macrophage-derived foam cell infiltration via lysophosphatidylcholine-mediated expression of adhesion molecules and chemokines in glomerular resident cells.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26072030      PMCID: PMC4530130          DOI: 10.1016/j.ajpath.2015.04.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

Review 1.  Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes.

Authors:  R Nosadini; G Tonolo
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-12-24       Impact factor: 4.222

2.  Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine.

Authors:  K Kugiyama; S Sugiyama; N Ogata; H Oka; H Doi; Y Ota; H Yasue
Journal:  Atherosclerosis       Date:  1999-03       Impact factor: 5.162

3.  Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells.

Authors:  Nambi Aiyar; Jyoti Disa; Zhaohui Ao; Haisong Ju; Sandhya Nerurkar; Robert N Willette; Colin H Macphee; Douglas G Johns; Stephen A Douglas
Journal:  Mol Cell Biochem       Date:  2006-08-08       Impact factor: 3.396

4.  Identification of oxidized low density lipoprotein in human renal biopsies.

Authors:  H S Lee; Y S Kim
Journal:  Kidney Int       Date:  1998-09       Impact factor: 10.612

5.  Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.

Authors:  M B Stokes; A M Valeri; G S Markowitz; V D D'Agati
Journal:  Kidney Int       Date:  2006-10-04       Impact factor: 10.612

6.  Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury.

Authors:  M Hattori; D J Nikolic-Paterson; K Miyazaki; N M Isbel; H Y Lan; R C Atkins; H Kawaguchi; K Ito
Journal:  Kidney Int Suppl       Date:  1999-07       Impact factor: 10.545

7.  Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis.

Authors:  Takako Asano; Fumio Niimura; Ira Pastan; Agnes B Fogo; Iekuni Ichikawa; Taiji Matsusaka
Journal:  J Am Soc Nephrol       Date:  2005-06-29       Impact factor: 10.121

8.  Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.

Authors:  Bryan L Wharram; Meera Goyal; Jocelyn E Wiggins; Silja K Sanden; Sabiha Hussain; Wanda E Filipiak; Thomas L Saunders; Robert C Dysko; Kenji Kohno; Lawrence B Holzman; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2005-08-17       Impact factor: 10.121

9.  Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury.

Authors:  Taiji Matsusaka; Jing Xin; Suguri Niwa; Kazuto Kobayashi; Akira Akatsuka; Hiroomi Hashizume; Qing-Cheng Wang; Ira Pastan; Agnes B Fogo; Iekuni Ichikawa
Journal:  J Am Soc Nephrol       Date:  2005-03-09       Impact factor: 10.121

10.  Lysophosphatidylcholine induces the production of IL-1beta by human monocytes.

Authors:  Y Liu-Wu; E Hurt-Camejo; O Wiklund
Journal:  Atherosclerosis       Date:  1998-04       Impact factor: 5.162

View more
  16 in total

1.  Complex glomerular pathology of thrombotic microangiopathy and focal segmental glomerulosclerosis forms tumor-like mass in a renal transplant donor with severe renovascular hypertension.

Authors:  Michio Nagata; Yutaka Yamaguchi; Daisuke Toki; Izumi Yamamoto; Hiroaki Shinmura; Hiroshi Kawaguchi
Journal:  CEN Case Rep       Date:  2016-09-26

Review 2.  Focal segmental glomerulosclerosis; why does it occur segmentally?

Authors:  Michio Nagata; Namiko Kobayashi; Satoshi Hara
Journal:  Pflugers Arch       Date:  2017-06-29       Impact factor: 3.657

3.  Glomerular Lipidosis in Dogs.

Authors:  Rebecca A Kohnken; Hayley Amerman; Cathy A Brown; Eva Furrow; George E Lees; Rachel E Cianciolo
Journal:  Vet Pathol       Date:  2017-06-05       Impact factor: 2.221

Review 4.  The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease.

Authors:  Yu Sun; Sijia Cui; Yunfeng Hou; Fan Yi
Journal:  Kidney Dis (Basel)       Date:  2021-09-01

5.  Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka and Homozygous Apolipoprotein E2/2 without Dyslipidemia, with Characteristic Electron-Dense Deposits.

Authors:  Akihiko Koshino; Chikako Takaeda; Takahiro Matsuno; Shinji Kitajima; Yasunori Iwata; Norihiko Sakai; Kiyotaka Nagahama; Yo Niida; Takao Saito; Hitoshi Yokoyama; Takashi Wada
Journal:  Case Rep Nephrol Dial       Date:  2022-06-10

6.  Distinct urinary lipid profile in children with focal segmental glomerulosclerosis.

Authors:  Elif Erkan; Xueheng Zhao; Kenneth Setchell; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2015-11-04       Impact factor: 3.714

7.  Urinary levels of podocyte-derived microparticles are associated with the progression of chronic kidney disease.

Authors:  Jian Lu; Ze-Bo Hu; Pei-Pei Chen; Chen-Chen Lu; Jia-Xiu Zhang; Xue-Qi Li; Ben-Yin Yuan; Si-Jia Huang; Kun-Ling Ma
Journal:  Ann Transl Med       Date:  2019-09

8.  Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease.

Authors:  Koryun Mirzoyan; Anna Baïotto; Aude Dupuy; Dimitri Marsal; Colette Denis; Claire Vinel; Pierre Sicard; Justine Bertrand-Michel; Jean-Loup Bascands; Joost P Schanstra; Julie Klein; Jean-Sébastien Saulnier-Blache
Journal:  J Physiol Biochem       Date:  2016-09-17       Impact factor: 4.158

Review 9.  Adaptive and maladaptive roles of lipid droplets in health and disease.

Authors:  Jeffrey D Pressly; Margaret Z Gurumani; Javier T Varona Santos; Alessia Fornoni; Sandra Merscher; Hassan Al-Ali
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-02       Impact factor: 4.249

10.  The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis.

Authors:  Yi Chen; Liyu Lin; Xuan Tao; Yankun Song; Jiong Cui; Jianxin Wan
Journal:  BMC Nephrol       Date:  2019-03-28       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.